
Gailene Gabel
Examiner (ID: 17209, Phone: (571)272-0820 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1677, 1641, 1678 |
| Total Applications | 1464 |
| Issued Applications | 864 |
| Pending Applications | 208 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18333477
[patent_doc_number] => 20230125425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => TRADITIONAL CHINESE MEDICINE EXTRACT COMPOSITION WITH FUNCTION OF REGULATING DEPRESSIVE EMOTION AND PREPARATION METHOD AND TRADITIONAL CHINESE MEDICINE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/043737
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043737
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043737 | TRADITIONAL CHINESE MEDICINE EXTRACT COMPOSITION WITH FUNCTION OF REGULATING DEPRESSIVE EMOTION AND PREPARATION METHOD AND TRADITIONAL CHINESE MEDICINE PREPARATION THEREOF | Dec 19, 2019 | Abandoned |
Array
(
[id] => 18642344
[patent_doc_number] => 11766397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Bioactive compositions comprising
[patent_app_type] => utility
[patent_app_number] => 16/706677
[patent_app_country] => US
[patent_app_date] => 2019-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20894
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16706677
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/706677 | Bioactive compositions comprising | Dec 6, 2019 | Issued |
Array
(
[id] => 17383938
[patent_doc_number] => 20220031790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHOD FOR PRODUCING RED PERILLA LEAF EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/297299
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17297299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/297299 | METHOD FOR PRODUCING RED PERILLA LEAF EXTRACT | Nov 25, 2019 | Abandoned |
Array
(
[id] => 17020912
[patent_doc_number] => 20210244783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => COMPOSITION COMPRISING CLEMATIS MANDSHURICA EXTRACT AS ACTIVE INGREDIENT FOR COGNITIVE FUNCTION IMPROVEMENT
[patent_app_type] => utility
[patent_app_number] => 17/054764
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054764 | COMPOSITION COMPRISING CLEMATIS MANDSHURICA EXTRACT AS ACTIVE INGREDIENT FOR COGNITIVE FUNCTION IMPROVEMENT | Nov 19, 2019 | Abandoned |
Array
(
[id] => 17441832
[patent_doc_number] => 20220062337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => TREATMENT AND DIAGNOSIS OF AUTOANTIBODY-MEDIATED EYE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/292094
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292094 | TREATMENT AND DIAGNOSIS OF AUTOANTIBODY-MEDIATED EYE DISEASES | Nov 7, 2019 | Pending |
Array
(
[id] => 15862967
[patent_doc_number] => 20200138887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
[patent_app_type] => utility
[patent_app_number] => 16/675264
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16675264
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/675264 | METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) | Nov 5, 2019 | Abandoned |
Array
(
[id] => 17383028
[patent_doc_number] => 20220030880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => BIO-PESTICIDE OIL FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/290629
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290629 | BIO-PESTICIDE OIL FORMULATION | Oct 29, 2019 | Pending |
Array
(
[id] => 15738451
[patent_doc_number] => 20200108113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => NOVEL BOTANICAL FORMULATION FOR TREATING SICKLE CELL DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/597527
[patent_app_country] => US
[patent_app_date] => 2019-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16597527
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/597527 | Botanical formulation for treating sickle cell disease | Oct 8, 2019 | Issued |
Array
(
[id] => 16882918
[patent_doc_number] => 20210169113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => COMPOSITION FOR IMPROVING INTESTINAL FLORA
[patent_app_type] => utility
[patent_app_number] => 17/251027
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251027 | COMPOSITION FOR IMPROVING INTESTINAL FLORA | Oct 3, 2019 | Abandoned |
Array
(
[id] => 16189342
[patent_doc_number] => 20200230191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => MINT ESSENTIAL OILS INHIBIT HRAS-Q61L MUTANT KERATINOCYTE ACTIVITY AND PREVENT SKIN CARCINOGENESIS
[patent_app_type] => utility
[patent_app_number] => 16/585984
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16585984
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/585984 | Mint essential oils inhibit | Sep 26, 2019 | Issued |
Array
(
[id] => 17148395
[patent_doc_number] => 11141447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Composition for treatment and management of addiction and method of preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/585645
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 15878
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16585645
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/585645 | Composition for treatment and management of addiction and method of preparation thereof | Sep 26, 2019 | Issued |
Array
(
[id] => 15708725
[patent_doc_number] => 20200101128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => COMPOSITION, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF IN THE PREVENTION AND TREATMENT OF MAMMARY GLAND DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/584815
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584815
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/584815 | Composition, preparation method thereof, and application thereof in the prevention and treatment of mammary gland disease | Sep 25, 2019 | Issued |
Array
(
[id] => 17342075
[patent_doc_number] => 20220008406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => USE OF NUCIFERIN AND LOTUS LEAF EXTRACT IN THE PREPARATION OF A MEDICAMENT FOR TREATING ATROPHIC GASTRITIS AND/OR BLOCKING TRANSFORMATION OF GASTRITIS INTO CANCER
[patent_app_type] => utility
[patent_app_number] => 17/276146
[patent_app_country] => US
[patent_app_date] => 2019-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276146 | USE OF NUCIFERIN AND LOTUS LEAF EXTRACT IN THE PREPARATION OF A MEDICAMENT FOR TREATING ATROPHIC GASTRITIS AND/OR BLOCKING TRANSFORMATION OF GASTRITIS INTO CANCER | Sep 8, 2019 | Abandoned |
Array
(
[id] => 17183825
[patent_doc_number] => 20210330710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => INFLAMMATORY CYTOKINE PRODUCTION INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/273917
[patent_app_country] => US
[patent_app_date] => 2019-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273917 | INFLAMMATORY CYTOKINE PRODUCTION INHIBITOR | Sep 3, 2019 | Abandoned |
Array
(
[id] => 17140193
[patent_doc_number] => 20210308204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => FORMULATIONS CONTAINING LIPOPHILIC EXTRACTS OF SPICY EDIBLE PLANTS USEFUL IN CONTROLLING PAIN AND INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/266760
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266760 | FORMULATIONS CONTAINING LIPOPHILIC EXTRACTS OF SPICY EDIBLE PLANTS USEFUL IN CONTROLLING PAIN AND INFLAMMATION | Aug 6, 2019 | Abandoned |
Array
(
[id] => 16853483
[patent_doc_number] => 20210154228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => ANGIOTENSIN I-CONVERTING ENZYME ACTIVITY INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/056887
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056887
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056887 | ANGIOTENSIN I-CONVERTING ENZYME ACTIVITY INHIBITOR | Jul 16, 2019 | Abandoned |
Array
(
[id] => 15493203
[patent_doc_number] => 20200046790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => Pain Relief Formulation and Method of Treatment
[patent_app_type] => utility
[patent_app_number] => 16/514391
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514391 | Pain Relief Formulation and Method of Treatment | Jul 16, 2019 | Abandoned |
Array
(
[id] => 16930891
[patent_doc_number] => 20210196780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => INFLAMMATORY CYTOKINE PRODUCTION INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/260891
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260891 | INFLAMMATORY CYTOKINE PRODUCTION INHIBITOR | Jul 15, 2019 | Abandoned |
Array
(
[id] => 17349994
[patent_doc_number] => 11224612
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-01-18
[patent_title] => Glycosaminoglycans from
[patent_app_type] => utility
[patent_app_number] => 16/507808
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23447
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16507808
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/507808 | Glycosaminoglycans from | Jul 9, 2019 | Issued |
Array
(
[id] => 17109929
[patent_doc_number] => 20210290526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => LIPID EMULSION FOR PARENTERAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/257229
[patent_app_country] => US
[patent_app_date] => 2019-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257229
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257229 | Lipid emulsion for parenteral administration | Jun 30, 2019 | Issued |